Circulating stromal cells in resectable pancreatic cancer correlates to pathological stage and predicts for poor clinical outcomes

Kirby P. Gardner(Rutgers, The State University of New Jersey), Daniel L. Adams(Creatv MicroTech (United States)), Cha‐Mei Tang(Creatv MicroTech (United States)), Susan Tsai(The Ohio State University Wexner Medical Center), Mohammed Aldakkak(Medical College of Wisconsin)
npj Precision Oncology
March 19, 2021
10.1038/s41698-021-00161-8
Cited by 25

Related Papers

Sarcopenia negatively impacts short-term outcomes in patients undergoing hepatic resection for colorectal liver metastasis
|HPB|2011|413
Development of primary human pancreatic cancer organoids, matched stromal and immune cells and 3D tumor microenvironment models
|BMC Cancer|2018|391
Plasma extracellular RNA profiles in healthy and cancer patients
|Scientific Reports|2016|294
Circulating giant macrophages as a potential biomarker of solid tumors
|Proceedings of the National Academy of Sciences|2014|281
Microwave Ablation for Hepatic Malignancies
|Annals of Surgery|2013|254